The Kirby Institute is a leading global research institute dedicated to the prevention and treatment of infectious diseases.
We were established in 1986 in response to the then emerging HIV epidemic. We now contribute to knowledge on a broad range of diseases, including viral hepatitis and sexually transmissible infections.
Our primary work relates to the coordination of national surveillance programs, population health and epidemiological research, clinical and behavioural research and clinical trials. Our research projects are conducted in partnership with communities most affected by epidemics. Together we implement trials of behavioural and biomedical interventions designed to prevent the spread of infectious diseases in vulnerable populations.
Our work in the laboratory is focused on finding ways to control infections, develop new therapies and ultimately towards the development of preventative vaccines. Outside of the laboratory, we provide critical leadership to decision makers in Australia and internationally on the most effective, efficient and sustainable strategies to address deadly epidemics.
Our research has increasingly taken on a regional focus. Over the past two decades, we have developed collaborative programs in several countries that have involved training health workers and health researchers in the Asia Pacific region, advising governments on public health and clinical policy, informing international treatment guidelines and working to increase access to essential medicines. We have particularly strong partnerships in Thailand, Papua New Guinea, Indonesia, Myanmar, Fiji and the Solomon Islands.
Our world-class team comprises over 300 public health, clinical and laboratory scientists, research assistants, postgraduate students and professional staff.